Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis
- PMID: 18430720
- DOI: 10.1093/jac/dkn178
Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis
Abstract
Background: One-third of the world's population is infected with the dormant tuberculosis bacillus, and there have been no new antimycobacterial compounds with new modes of action for over 30 years. Extensively drug-resistant tuberculosis is resistant to first- and second-line drugs, which can have severe side effects, and requires the breakthrough of new antituberculotics and resistance-modifying agents. Efflux pumps can cause multidrug resistance and have recently evoked much interest as promising new targets in antimicrobial therapy.
Objectives: The study was performed to set up an ethidium bromide (EtBr) efflux assay in Mycobacterium smegmatis mc(2)155 for testing plant natural compounds as mycobacterial efflux pump inhibitors (EPIs).
Methods: After determining the MICs of the putative EPIs, they were tested for synergistic effects with EtBr prior to the efflux assay.
Results: We established an EtBr efflux assay in M. smegmatis mc(2)155. The isoflavone biochanin A exhibited efflux pump inhibiting activity comparable to that of verapamil. The flavone luteolin and the stilbene resveratrol were less active.
Conclusions: A new assay was established to observe the EtBr efflux in M. smegmatis and was applied to evaluate plant phenolic compounds. Our results highlighted that the isoflavonoid biochanin A exhibited better EPI activities than other flavonoids in mycobacteria.
Similar articles
-
Phenylpropanoids of Alpinia galanga as efflux pump inhibitors in Mycobacterium smegmatis mc² 155.Fitoterapia. 2012 Oct;83(7):1248-55. doi: 10.1016/j.fitote.2012.06.008. Epub 2012 Jun 23. Fitoterapia. 2012. PMID: 22735598
-
Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance.BMC Microbiol. 2011 Feb 18;11:35. doi: 10.1186/1471-2180-11-35. BMC Microbiol. 2011. PMID: 21332993 Free PMC article.
-
Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.J Antimicrob Chemother. 2008 May;61(5):1076-82. doi: 10.1093/jac/dkn070. Epub 2008 Feb 29. J Antimicrob Chemother. 2008. PMID: 18310137
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Role of mycobacterial efflux transporters in drug resistance: an unresolved question.FEMS Microbiol Rev. 2006 Jan;30(1):36-52. doi: 10.1111/j.1574-6976.2005.00002.x. FEMS Microbiol Rev. 2006. PMID: 16438679 Review.
Cited by
-
A comprehensive account on ethnobotany, phytochemistry and pharmacological insights of genus Celtis.Heliyon. 2024 Apr 25;10(9):e29707. doi: 10.1016/j.heliyon.2024.e29707. eCollection 2024 May 15. Heliyon. 2024. PMID: 38726115 Free PMC article. Review.
-
Biochanin A Inhibits the Growth and Biofilm of Candida Species.Pharmaceuticals (Basel). 2024 Jan 9;17(1):89. doi: 10.3390/ph17010089. Pharmaceuticals (Basel). 2024. PMID: 38256922 Free PMC article.
-
Antimycobacterial Precatorin A Flavonoid Displays Antibiofilm Activity against Mycobacterium bovis BCG.ACS Omega. 2023 Oct 20;8(43):40665-40676. doi: 10.1021/acsomega.3c05703. eCollection 2023 Oct 31. ACS Omega. 2023. PMID: 37929145 Free PMC article.
-
A Dietary Source of High Level of Fluoroquinolone Tolerance in mcr-Carrying Gram-Negative Bacteria.Research (Wash D C). 2023 Oct 6;6:0245. doi: 10.34133/research.0245. eCollection 2023. Research (Wash D C). 2023. PMID: 37808177 Free PMC article.
-
Advances in the Discovery of Efflux Pump Inhibitors as Novel Potentiators to Control Antimicrobial-Resistant Pathogens.Antibiotics (Basel). 2023 Sep 7;12(9):1417. doi: 10.3390/antibiotics12091417. Antibiotics (Basel). 2023. PMID: 37760714 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
